Hims & Hers Health, Inc. HIMS has seen a surge in retail investor interest, which positions it as one of the most high-profile candidates for the next "meme stock" rally. Hims & Hers stock has many of the key ingredients for a retail-driven rally, including exceptionally high short interest and viral attention on social media platforms, such as Reddit. Click here to view the option chain, then analyze potential trades and assess market sentiment for Hims & Hers Health. Out-Sized Short Interest More than a t ...

Shares of Dow Inc. DOW continue to trend lower Friday. They were hit hard after the company posted weak Q2 results yesterday.  But the bulls may be about to take over.Midland, Michigan-based Dow is our Stock of the Day. There may have been a capitulation in the selling, the shares are oversold, and they have reached a possible support level. These three dynamics could all be bullish.More than 65 million shares of Dow traded yesterday. This was the largest volume ever. It may signal a capitulation by the sel ...

Rocket Pharmaceuticals, Inc. RCKT, a firm focused on developing cardiovascular gene therapy, announced a strategic corporate reorganization to extend its runway.The restructuring and reprioritization initiative focuses Rocket’s resources on the adeno-associated virus (AAV) cardiovascular platform, comprised of clinical programs in Danon disease, PKP2-associated arrhythmogenic cardiomyopathy (PKP2-ACM), and BAG3-associated dilated cardiomyopathy (BAG3-DCM), as well as submitting the completed responses to th ...

Mobileye Global MBLY stock fell on Thursday after it reported its fiscal second-quarter 2025 results.The autonomous firm reported a quarterly revenue growth of 15% year-on-year to $506.00 million, beating the analyst consensus estimate of $463.26 million. Adjusted EPS of 13 cents topped the analyst consensus estimate of 9 cents. Mobileye raised its fiscal 2025 revenue outlook to $1.765 billion- $1.885 billion (prior $1.690 billion-$1.810 billion) versus the $1.770 billion analyst consensus estimate and adju ...

Tesla Inc TSLA is Elon Musk's high-voltage headline machine — but behind every Model Y shipped are a dozen quiet gainers powering the EV push. As Musk teases robotaxis and self-driving breakthroughs, the real alpha might lie with the companies that enable him.Track TSLA’s stock movements here.Take ON Semiconductor Corp ON, a leader in silicon carbide chips critical for EV efficiency. Tesla has leaned heavily on silicon carbide to improve performance in its vehicles, and ON is a key supplier riding that adop ...

Despite all the noise surrounding tariffs and the budget bill this year, seasonality has held up very well. In fact, seasonality has become my favorite backdrop to use when looking for price action to trade on. That’s why my favorite trade setup for this coming week is a long trade on Ross Stores ROST, extending well into January 2026.Here are the details.Missed the First Half Rally? Here's Where the Real Opportunity StartsThe next wave of market gains won't come from chasing headlines, it'll come from spot ...

Imagine you stepped into the dimly lit hospital meeting room to pitch a new cancer‑diagnostic deal. You flick through slides powered by Palantir Technologies Inc.'s PLTR Foundry platform, showcasing data transparency and precision that would make legacy pharma pipelines look prehistoric.Track Palantir’s stock moves here.Down the hall, Tempus AI Inc TEM had its own room, where genomics-powered diagnostics promised to cut months off drug development timelines. Across the corridor, Recursion Pharmaceuticals In ...

Edwards Lifesciences’ EW stock surged Friday following a strong second-quarter 2025 earnings report that saw the medical device innovator surpass revenue and earnings expectations, driven by significant growth across its heart valve therapies.The strong performance prompted the company to raise its full-year sales guidance, signaling renewed momentum in its core markets. The heart devices company reported sales of $1.53 billion on Thursday after hours, beating the consensus of $1.49 billion and within the m ...

In the retail world, LVMH Moet Hennessy Louis Vuitton SE LVMHF has long strutted the global catwalk like royalty. But lately, the spotlight has shifted. Ulta Beauty Inc ULTA is having a Beyoncé moment—taking center stage, setting the tempo, and leaving the luxury titan looking like a backup dancer trying to keep up with the choreography.Track ULTA’s price movement here.Beauty Outshines Luxury In 2025Ulta Beauty's stock is up 19.65% year to date, outperforming broader retail benchmarks and shrugging off fear ...

One area of concern was Alphabet's updated capital expenditure forecast, which was raised to $85 billion for 2025—up 13% from prior guidance. Two-thirds will be allocated to servers, and the rest to data centers, reflecting the company's significant investment in AI infrastructure. Sheridan noted this raised questions about long-term capital intensity and returns but said management remains optimistic about the payoff. Sheridan highlighted the increasing usage of Gemini, AI agents, and multimodal search as ...